Abstract
This article reviews the main data regarding ticagrelor, prasugrel, and clopidogrel therapy in patients with ST-segment elevation myocardial infarction (STEMI). Additional topics include new evidence regarding the timing of antiplatelet loading, managing antiplatelet therapy in patients undergoing CABG surgery, as well as new strategies for managing atrial fibrillation and concomitant coronary artery disease and acute coronary syndromes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
